See what CanVECTOR members are publishing to advance the field of venous thromboembolism
Publications since 2016 that are linked to venous thromboembolism and/or anticoagulant therapy

Publications for Aurelien Delluc

Updated daily

Back to Member List

#	PubMedId	Deleted	Publication
	36841648	0	Mulder FI, Kraaijpoel N, Carrier M, et al. Platelet RNA sequencing for cancer screening in patients with unprovoked venous thromboembolism: a prospective cohort study. J Thromb Haemost. 2023 Jan 11:S1538-7836(23)00031-4. doi: 10.1016/j.jtha.2023.01.003.
	36809776	0	Pradier M, Rodger MA, Ghanima W, et al. Performance and head-to head comparison of three clinical models to predict occurrence of post-thrombotic syndrome. A validation study. Thromb Haemost. 2023 Feb 21. doi: 10.1055/a-2039-3388.
	36696186	0	Caiano LM, Drury T, Zahrai A, et al. Role of statins in the prevention of post-thrombotic syndrome after a deep vein thrombosis event: a systematic review and meta-analysis. J Thromb Haemost. 2022 Dec 22:S1538-7836(22)18246-2. doi: 10.1016/j.jtha.2022.12.008.
	36268462	0	Attard LM, Gatt A, Bertoletti L, et al. Direct Oral Anticoagulants for the Prevention and Acute Treatment of Cancer-Associated Thrombosis. Vasc Health Risk Manag. 2022 Oct 13;18:793-807. doi: 10.2147/VHRM.S271411. eCollection 2022.
	36210560	0	Delluc A, Robin P. (18)F-Fluorodeoxyglucose positron emission/computed tomography for occult cancer among patients with unprovoked venous thromboembolism: What do we know? Thromb Res. 2022 May;213 Suppl 1:S42-S45. doi: 10.1016/j.thromres.2022.01.018. Epub 2022 May 26.
	35439303	0	Ageno W, Beyer-Westendorf J, Contino L, et al. Rivaroxaban for the treatment of noncirrhotic splanchnic vein thrombosis: an interventional prospective cohort study. Blood Adv. 2022 Apr 19. pii: 484971. doi: 10.1182/bloodadvances.2022007397.
	35344784	0	Delluc A, Ghanima W, Kovacs MJ, et al. Prevention of post-thrombotic syndrome with rosuvastatin: A multicenter randomized controlled pilot trial (SAVER). Thromb Res. 2022 Mar 19;213:119-124. doi: 10.1016/j.thromres.2022.03.014.
	35021257	0	Ng S, Rodger MA, Ghanima W, et al. External validation of the patient reported Villalta scale for the diagnosis of post-thrombotic syndrome. Thromb Haemost. 2022 Jan 12. doi: 10.1055/a-1738-1313.
	34852380	0	Makedonov I, Kahn SR, Abdulrehman J, et al. Prevention of the post thrombotic syndrome with anticoagulation: a narrative review. Thromb Haemost. 2021 Dec 1. doi: 10.1055/a-1711-1263.
	34845714	0	Delluc A, Wang TF. How to treat incidental pulmonary embolism in cancer patients? Recent advances. Kardiol Pol. 2021 Nov 30. pii: VM/OJS/J/87173. doi: 10.33963/KP.a2021.0164.
	34795036	0	Caiano L, Sharkey R, Rodger MA, et al. Evaluation of the PADIS score stratifying risk for venous thromboembolism recurrence after a first unprovoked pulmonary embolism. Results from the REVERSE study. Eur Respir J. 2021 Nov 18. pii: 13993003.01801-2021. doi: 10.1183/13993003.01801-2021.
	34742140	0	Nayak AL, Zahrai A, Mallick R, et al. Efficacy of primary prevention of venous thromboembolism among subgroups of cancer patients undergoing chemotherapy: A post- hoc analysis of the AVERT trial. Thromb Res. 2021 Oct 26;208:79-82. doi: 10.1016/j.thromres.2021.10.018.
	34715510	0	Li A, Brandt W, Brown C, et al. Efficacy and safety of primary thromboprophylaxis for the prevention of venous thromboembolism in patients with cancer and a central venous catheter: A systematic review and meta-analysis. Thromb Res. 2021 Oct 24;208:58-65. doi: 10.1016/j.thromres.2021.10.012.
	34564938	0	Delluc A, Ghanima W, Kovacs MJ, et al. Statins for venous event reduction in patients with venous thromboembolism: A multicenter randomized controlled pilot trial assessing feasibility. J Thromb Haemost. 2021 Sep 26. doi: 10.1111/jth.15537.
	34399433	0	Wang TF, Carrier M, Fournier K, et al. Oral Anticoagulant Use in Patients with Morbid Obesity: A Systematic Review and Meta-Analysis. Thromb Haemost. 2021 Aug 16. doi: 10.1055/a-1588-9155.
	34255928	0	Tritschler T, Salvatore SP, Kahn SR, et al. ISTH definition of pulmonary embolism-related death and classification of the cause of death in venous thromboembolism studies: Validation in an autopsy cohort. J Thromb Haemost. 2021 Oct;19(10):2514-2521. doi: 10.1111/jth.15458. Epub 2021 Aug 1.
	34161655	0	Caiano L, Carrier M, Marshall A, et al. Outcomes among patients with cancer and incidental or symptomatic venous thromboembolism: A systematic review and meta-analysis. J Thromb Haemost. 2021 Oct;19(10):2468-2479. doi: 10.1111/jth.15435. Epub 2021 Jul 12.
	33190023	0	Roberge G, Delluc A. Challenging anticoagulation cases: A case of incidental subsegmental pulmonary embolism in a patient with cancer. Thromb Res. 2021 Jan;197:77-83. doi: 10.1016/j.thromres.2020.10.033. Epub 2020 Nov 6.
	32654308	0	AlBader M, Le Gal G, Rodger MA, et al. Yield of ultrasonography in patients with or without post-thrombotic syndrome for diagnosis of suspected recurrent ipsilateral deep vein thrombosis. J Thromb Haemost. 2020 Oct;18(10):2654-2657. doi: 10.1111/jth.14996. Epub 2020 Aug 28.
	32416310	0	Delluc A, Lacut K, Rodger MA. Arterial and venous thrombosis: What's the link? A narrative review. Thromb Res. 2020 Jul;191:97-102. doi: 10.1016/j.thromres.2020.04.035. Epub 2020 Apr 27.
	32395827	0	Wang TF, Delluc A. Thromboprophylaxis in patients with multiple myeloma. Br J Haematol. 2020 Aug;190(4):493-494. doi: 10.1111/bjh.16731. Epub 2020 May 12.
	31899848	0	Galanaud JP, Righini M, Le Collen L, et al. Long-term risk of postthrombotic syndrome after symptomatic distal deep vein thrombosis: The CACTUS-PTS study. J Thromb Haemost. 2020 Apr;18(4):857-864. doi: 10.1111/jth.14728. Epub 2020 Feb 11.
	31872492	0	Miranda S, Park J, Le Gal G, et al. Prevalence of confirmed antiphospholipid syndrome in 18-50 years unselected patients with first unprovoked venous thromboembolism. J Thromb Haemost. 2020 Apr;18(4):926-930. doi: 10.1111/jth.14720. Epub 2020 Feb 17.
	31582557	0	Stephen MS, Castellucci L, Carrier M, et al. Safety of using direct oral anticoagulants in the diagnostic workup of outpatients with suspicion of acute venous thromboembolism. Haematologica. 2020 Jun;105(6):e307-e309. doi: 10.3324/haematol.2019.232884. Epub 2019 Oct 3.
	31279158	0	Rodger MA, Miranda S, Delluc A, et al. Management of suspected and confirmed recurrent venous thrombosis while on anticoagulant therapy. What next? Thromb Res. 2019 Aug;180:105-109. doi: 10.1016/j.thromres.2019.06.017. Epub 2019 Jun 26.
	31273089	0	Delluc A, Miranda S, Exter PD, et al. Accuracy of the Ottawa score in risk stratification of recurrent venous thromboembolism in patients with cancer-associated venous thromboembolism: a systematic review and meta-analysis. Haematologica. 2020 May;105(5):1436-1442. doi: 10.3324/haematol.2019.222828. Epub 2019 Jul 4.
	31207027	0	Delluc A, Wang TF, Yap ES, et al. Anticoagulation of cancer patients with non-valvular atrial fibrillation receiving chemotherapy: Guidance from the SSC of the ISTH. J Thromb Haemost. 2019 Aug;17(8):1247-1252. doi: 10.1111/jth.14478. Epub 2019 Jun 17.
	30685873	0	Rezig S, Mao RL, Couturaud F, et al. Incidence of Cancer after a Second Unprovoked Venous Thromboembolic Event. Thromb Haemost. 2019 Mar;119(3):490-495. doi: 10.1055/s-0039-1677745. Epub 2019 Jan 27.
	30268858	0	Robin P, Otten HM, Delluc A, et al. Effect of occult cancer screening on mortality in patients with unprovoked venous thromboembolism. Thromb Res. 2018 Nov;171:92-96. doi: 10.1016/j.thromres.2018.09.055. Epub 2018 Sep 23.
	30076179	0	Delluc A, Le Mao R, Tromeur C, et al. Incidence of upper-extremity deep vein thrombosis in western France: a community-based study. Haematologica. 2019 Jan;104(1):e29-e31. doi: 10.3324/haematol.2018.194951. Epub 2018 Aug 3.
	29880445	0	Delluc A, Clemons M. Poor outcomes after venous thromboembolism in cancer patients: It's time to change practice. Thromb Res. 2018 Nov;171:177-178. doi: 10.1016/j.thromres.2018.06.003. Epub 2018 Jun 2.
	29787944	0	Delluc A, Lacut K, Pan-Petesch B, et al. Statin exposure and thrombosis risk in patients with myeloproliferative neoplasms. Thromb Res. 2018 Jul;167:57-59. doi: 10.1016/j.thromres.2018.05.014. Epub 2018 May 16.
	29775482	0	Heraudeau A, Delluc A, Le Henaff M, et al. Risk of venous thromboembolism in association with factor V leiden in cancer patients - The EDITH case-control study. PLoS One. 2018 May 18;13(5):e0194973. doi: 10.1371/journal.pone.0194973. eCollection 2018.
	29522910	0	Delluc A, Ianotto JC, Tromeur C, et al. Real-world incidence of cancer following a first unprovoked venous thrombosis: Results from the EPIGETBO study. Thromb Res. 2018 Apr;164:79-84. doi: 10.1016/j.thromres.2018.02.151. Epub 2018 Mar 2.
	29402471	0	Bertoletti L, Benhamou Y, Bejot Y, et al. Direct oral anticoagulant use in patients with thrombophilia, antiphospholipid syndrome or venous thrombosis of unusual sites: A narrative review. Blood Rev. 2018 Jul;32(4):272-279. doi: 10.1016/j.blre.2018.01.002. Epub 2018 Apr 20.
	29164292	0	Mahe K, Delluc A, Chauveau A, et al. Incidence and impact of atrial arrhythmias on thrombotic events in MPNs. Ann Hematol. 2018 Jan;97(1):101-107. doi: 10.1007/s00277-017-3164-x. Epub 2017 Nov 21.
	29046258	0	De Moreuil C, Le Mao R, Tromeur C, et al. Association between statin exposure and venous thromboembolism risk in cancer patients. Data from the EDITH case-control study. Eur J Intern Med. 2017 Dec;46:e42-e44. doi: 10.1016/j.ejim.2017.10.008. Epub 2017 Oct 16.
	28988597	0	Dillinger JG, Aleil B, Cheggour S, et al. Dosing issues with non-vitamin K antagonist oral anticoagulants for the treatment of non-valvular atrial fibrillation: Why we should not underdose our patients. Arch Cardiovasc Dis. 2018 Feb;111(2):85-94. doi: 10.1016/j.acvd.2017.04.008. Epub 2017 Oct 2.
	28751412	0	Le Mao R, Tromeur C, Bazire A, et al. Risk of recurrent venous thromboembolism in COPD patients: results from a prospective cohort study. Eur Respir J. 2017 Jul 27;50(1). pii: 50/1/1700094. doi: 10.1183/13993003.00094-2017. Print 2017 Jul.
	28647342	0	Hemon F, Fouchard F, Tromeur C, et al. Association between hospitalization for acute medical illness and VTE risk: A lower efficacy of thromboprophylaxis in elderly patients? Results from the EDITH case-control study. Eur J Intern Med. 2017 Oct;44:39-43. doi: 10.1016/j.ejim.2017.05.029. Epub 2017 Jun 22.
	28623609	0	Ianotto JC, Couturier MA, Galinat H, et al. Administration of direct oral anticoagulants in patients with myeloproliferative neoplasms. Int J Hematol. 2017 Oct;106(4):517-521. doi: 10.1007/s12185-017-2282-5. Epub 2017 Jun 16.
	27766390	0	Ianotto JC, Chauveau A, Mottier D, et al. JAK2V617F and calreticulin mutations in recurrent venous thromboembolism: results from the EDITH prospective cohort. Ann Hematol. 2017 Mar;96(3):383-386. doi: 10.1007/s00277-016-2853-1. Epub 2016 Oct 20.
	27592403	0	Astruc N, Ianotto JC, Metges JP, et al. External validation of the modified Ottawa score for risk stratification of recurrent cancer-associated thrombosis. Eur J Intern Med. 2016 Dec;36:e11-e12. doi: 10.1016/j.ejim.2016.08.001. Epub 2016 Aug 31.
	27465905	0	Delluc A, Tromeur C, Le Ven F, et al. Current incidence of venous thromboembolism and comparison with 1998: a community-based study in Western France. Thromb Haemost. 2016 Oct 28;116(5):967-974. doi: 10.1160/TH16-03-0205. Epub 2016 Jul 28.
	26672686	0	Robin P, Le Roux PY, Planquette B, et al. Limited screening with versus without (18)F-fluorodeoxyglucose PET/CT for occult malignancy in unprovoked venous thromboembolism: an open-label randomised controlled trial. Lancet Oncol. 2016 Feb;17(2):193-199. doi: 10.1016/S1470-2045(15)00480-5. Epub 2015 Dec 8.
	26603493	0	Delluc A, Carrier M. Catheter-related thrombosis: Unresolved issues. Thromb Res. 2015 Dec;136(6):1055-6. doi: 10.1016/j.thromres.2015.10.027. Epub 2015 Oct 19.
	26538494	0	Andro M, Delluc A, Moineau MP, et al. Serum levels of 25(OH)D are not associated with venous thromboembolism in the elderly population. A case-control study. Thromb Haemost. 2016 Jan;115(1):169-75. doi: 10.1160/TH15-02-0148. Epub 2015 Nov 5.
	26452982	0	Le Moigne E, Tromeur C, Delluc A, et al. Risk of recurrent venous thromboembolism on progestin-only contraception: a cohort study. Haematologica. 2016 Jan;101(1):e12-4. doi: 10.3324/haematol.2015.134882. Epub 2015 Oct 9.
	26290216	0	Ianotto JC, Chauveau A, Luque Paz D, et al. Absence of CALR mutation among a cohort of 394 unselected patients with a first episode of unprovoked venous thromboembolism. Thromb Haemost. 2016 Jan;115(1):225-6. doi: 10.1160/TH15-02-0134. Epub 2015 Aug 20.
	25491940	0	Delluc A, Le Gal G, Scarvelis D, et al. Outcome of central venous catheter associated upper extremity deep vein thrombosis in cancer patients. Thromb Res. 2015 Feb;135(2):298-302. doi: 10.1016/j.thromres.2014.11.020. Epub 2014 Dec 2.
	25455997	0	Le Roux PY, Robin P, Delluc A, et al. Performance of 18F fluoro-2-desoxy-D-glucose positron emission tomography/computed tomography for the diagnosis of venous thromboembolism. Thromb Res. 2015 Jan;135(1):31-5. doi: 10.1016/j.thromres.2014.10.008. Epub 2014 Oct 20.